Home › Funds › ICONIQ Capital, LLC › RLAY
ICONIQ Capital, LLC position in RLAY
RELAY THERAPEUTICS INC · Health Care
ICONIQ Capital, LLC reported holding 94,697 shares of RLAY (RELAY THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$1.8M, representing 0.05% of its reported portfolio and ranking #44 among its reported holdings. ICONIQ Capital, LLC has disclosed RLAY holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ICONIQ Capital, LLC's RLAY position evolved
ICONIQ Capital, LLC first disclosed a stake in RLAY in Q3 2023 at 94,697 shares (US$796K). The position peaked in Q2 2026 at 94,697 shares, worth US$1.8M. Across 12 filings, ICONIQ Capital, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 94,697 shares valued at US$1.8M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 94.70K | $796.40K | New |
| Q4 2023 | 94.70K | $1.04M | Hold |
| Q1 2024 | 94.70K | $785.99K | Hold |
| Q2 2024 | 94.70K | $617.42K | Hold |
| Q3 2024 | 94.70K | $670.46K | Hold |
| Q4 2024 | 94.70K | $390.15K | Hold |
| Q1 2025 | 94.70K | $248.11K | Hold |
| Q2 2025 | 94.70K | $327.65K | Hold |
| Q3 2025 | 94.70K | $494.32K | Hold |
| Q4 2025 | 94.70K | $801.14K | Hold |
| Q1 2026 | 94.70K | $942.24K | Hold |
| Q2 2026 | 94.70K | $1.77M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RLAY and 13F data
RLAY (RELAY THERAPEUTICS INC) is a Health Care company. 65 other funds we track also report a position in RLAY — the largest reported positions include SB INVESTMENT ADVISERS (UK) LTD (US$522.1M), Casdin Capital (US$300.0M), PERCEPTIVE ADVISORS LLC (US$263.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RLAY
- SB INVESTMENT ADVISERS (UK) LTD 27.90M sh · $522.10M · Q2 2026
- Casdin Capital 16.04M sh · $300.02M · Q2 2026
- PERCEPTIVE ADVISORS LLC 14.11M sh · $263.93M · Q2 2026
- Commodore Capital LP 12.00M sh · $224.52M · Q2 2026
- Nextech Invest Ltd. 6.78M sh · $126.79M · Q2 2026
- Bellevue Group AG 6.19M sh · $115.74M · Q2 2026
- TCG Crossover Management, LLC 4.27M sh · $79.95M · Q2 2026
- Siren, L.L.C. 3.65M sh · $68.29M · Q2 2026
- Kynam Capital Management, LP 3.30M sh · $61.74M · Q2 2026
- Spruce Street Capital LP 2.98M sh · $55.83M · Q2 2026
- BAKER BROS. ADVISORS LP 2.83M sh · $52.89M · Q2 2026
- MPM BioImpact LLC 2.42M sh · $45.20M · Q2 2026
More on ICONIQ Capital, LLC
FAQ
How long has ICONIQ Capital, LLC held RLAY?
ICONIQ Capital, LLC has disclosed RLAY holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is ICONIQ Capital, LLC's current position in RLAY?
As of Q2 2026, ICONIQ Capital, LLC holds 94.70K shares of RLAY (RELAY THERAPEUTICS INC), valued at $1.77M, representing 0.05% of its reported portfolio and ranking #44.
Has ICONIQ Capital, LLC been buying or selling RLAY?
In the latest 13F filing (Q2 2026), ICONIQ Capital, LLC held unchanged its position in RLAY. The position peaked in Q2 2026 at 94.70K shares.
Which other funds hold RLAY?
Other major institutional holders of RLAY include SB INVESTMENT ADVISERS (UK) LTD, Casdin Capital, PERCEPTIVE ADVISORS LLC, among 65 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.